BASE Form 4: Matthew Cain Disposes 12,357 Shares; 852,949 Remain
Rhea-AI Filing Summary
Couchbase, Inc. (BASE) insider transaction: Matthew M. Cain, the company's Chair, President and CEO, reported a sale of 12,357 shares of common stock on 08/18/2025 at a weighted average price of $24.3469 per share under a Rule 10b5-1 trading plan adopted 10/03/2024. After the reported disposition, Mr. Cain beneficially owned 852,949 shares. The Form 4 was signed by Margaret Chow by power of attorney on 08/20/2025. The filer states the reported sale consisted of multiple transactions at prices ranging from $24.33 to $24.37 and offers to provide detailed price-by-price information on request.
Positive
- Transaction conducted under a Rule 10b5-1 trading plan, indicating pre-planned trades and reduced concern about trading on material nonpublic information.
- Timely and transparent disclosure of shares sold (12,357), weighted-average price ($24.3469), execution price range ($24.33–$24.37) and post-transaction beneficial ownership (852,949 shares).
- Filer offers to provide per-transaction pricing details on request, which supports transparency and auditability.
Negative
- None.
Insights
TL;DR: A routine, pre-planned insider sale by the CEO under a 10b5-1 plan; transparent disclosure of weighted-average price and remaining ownership.
The Form 4 documents a sale by the CEO executed pursuant to a Rule 10b5-1 plan adopted 10/03/2024, which typically limits claims of trading on material nonpublic information. The filing discloses the aggregate shares sold (12,357), the weighted-average price ($24.3469) and the residual beneficial ownership (852,949 shares). The filer also offers to provide per-transaction prices within the stated range. From a governance perspective, timely Form 4 disclosure and the 10b5-1 election enhance transparency and compliance; the filing contains no indication of unusual or undisclosed arrangements.
TL;DR: Transaction is a modest, pre-scheduled sale with limited direct impact on equity supply or valuation.
The reported disposition size is small relative to institutional or market volumes and the filing confirms multiple executions at prices between $24.33 and $24.37. The existence of a 10b5-1 plan reduces informational asymmetry concerns but does not provide detail on the plan's overall duration or remaining authorized volume. The filing is complete for the specific transaction and offers further granularity upon request, which supports auditability of the sale.